ST
SUPN icon

Spot Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Spot Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$232K Buy
+5,811
New +$251K ﹤0.01% 2144
2017
Q1 		– Sell
-8,542
Closed -$229K – 3295
2016
Q4 		$216K Buy
+8,542
New +$191K 0.01% 1879

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Spot Trading's SUPN Position: Q3 2017 in Review

Spot Trading opened a new position in Supernus Pharmaceuticals (SUPN) in Q3 2017: 5,811 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #2144 among its holdings. This is a return to the name: Spot Trading previously reported a position in SUPN as recently as Q4 2016.

Spot Trading first reported a position in SUPN in Q4 2016 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold SUPN as of Q3 2017.

  • Spot Trading held 5,811 shares of Supernus Pharmaceuticals worth $232K as of Q3 2017.
  • Supernus Pharmaceuticals was a new Spot Trading position in Q3 2017.
  • Supernus Pharmaceuticals made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2144 holding.
  • Spot Trading first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 2 quarters since.
  • 275 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.